Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vehicle cream (Braintree Laboratories) is an inactive topical formulation used as a placebo control in clinical trials evaluating the safety and efficacy of drug candidates for acne vulgaris, specifically the formulation known as BLI1100. Developed by Braintree Laboratories (now a part of Sebela Pharmaceuticals), this vehicle contains the same excipients and base components as the active BLI1100 cream but lacks the active pharmaceutical ingredient. In clinical studies, such as the Phase 2 trial NCT01514201, it serves to establish a baseline for comparison, allowing researchers to distinguish the therapeutic effects of the active drug from the potential effects of the cream base itself or the act of topical application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vehicle cream.